View Cart (0 items)

Pharmaceutical

Canada's drug spending growth slowed by generics

Market share is increasing for generics drugs, which are typically much cheaper than branded and patented drugs.
Read More

Many generic drugs fail to serve their purpose, doctors warn

Doctors and researchers have criticized the U.S. Food and Drug Administration (FDA) for failing to control the effectiveness of the vast majority of pharmaceutical products sold in the United States.
Read More

Endo Pharmaceuticals settles lawsuit over unlawful marketing

Pharmaceutical companies Endo Pharmaceuticals and Endo Health Solutions will have to pay $192.7 million to resolve criminal and civil charges related to their marketing policy for the product Lidoderm.
Read More

AstraZeneca, Merck gain share on Glaxo's asthma treatment drug

Competition on the U.S. pharmaceutical market has never been more fierce. Generic drugs are taking decisive steps onto the market, gaining a bigger share wherever they are allowed.
Read More

Plastics, polymers to dominate global pharmaceutical packaging market

Over the years through 2018, the global pharmaceutical packaging market is predicted to reach $78.79 billion, with Europe, Japan and the U.S. accounting for about 70% of the entire market.
Read More

Mexico's Neolpharma opens R&D facility in Puerto Rico

The Center for the Development and Innovation of Pharmaceutical Products, or Cediprof, will focus on research and experimentation of generic drugs.
Read More

Another Ranbaxy facility lands on FDA blacklist

The U.S. Food and Drug Administration (FDA) has added Ranbaxy's Toansa plant to the list of Indian facilities included on the consent decree dated January 2012.
Read More

Novo Nordisk locked in legal battle over generic drug

Danish pharmaceutical giant Novo Nordisk is being sued by several healthcare purchasing companies that claim the drug maker wrongfully kept generic copies of its diabetes drug Prandin off the market.
Read More

US pharmaceutical spending slightly down from 2012 levels

Expenditure on pharmaceuticals in 2013 is predicted to register a minor decline of 0.5% dipping to $341.2 billion from $343 billion in 2012.
Read More

Global spending on medicines to grow by up to 6% per year through 2017

The key factors that will drive global drug markets are better access to medicines due to rising disposable income in developing countries and more favorable economic conditions in emerging markets.
Read More